Aims and Scope
Personalized Medicine is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. It publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). The journal recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, It aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities. Unique features of this journal:
- • Manuscripts regarding original research and ideas will be particularly welcomed. PM also accepts reviews, clinical studies and case reports, communications, and short notes.
- • Computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
- • There is no limit to publication length: our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.
The topics related to this journal include but are not limited to:
- Omics technologies (genomics, transcriptomics, proteomics, epigenomics, metabolomics, lipidomics, interferomics)
- Biomarker research, development and application
- Bioethics
- Personalized health informatics (data mining, diagnosis, analysis)
- Legal and social consequences of personalized medicine
- Genetic testing
- Preventative treatment and targeted therapy
- Genetics and the biochemistry and physiology of drug action, uptake and metabolism
- Genetics based vaccine development
- Prediction-based drug safety
- Bioinformatics (databases, data mining, modeling and simulation, signal/image analysis)
- Next-generation sequencing developments and genome-wide association studies
- Drug target discovery and development
- Pharmacoeconomics
- Regulatory environments
- Personalization of health interventions for improved safety, efficacy and sustainability. (e.g., drug therapy, nutrition) and variability in environmentbiochip/microarray technologies
- Disease screening and molecular diagnostics for risk factors
- Integration with therapy
- Information for drug selection and dosage
- Genetics-based clinical trials methodology
- Understanding adverse drug reactions
Guidelines for preparing your manuscript can be found in the Manuscript Preparation Guidelines. Once your manuscript is ready, you may proceed to the Submission page to complete the process.
